AstraZeneca Plc may sell some of its medicines directly to patients in the US, joining several other drugmakers that have plans to bypass middlemen or are considering them.

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly transferring manufacturing” across the Atlantic.

AstraZeneca's quarterly revenue beat expectations, boosted by its oncology and biopharmaceuticals segments and strong U.S. demand. The Anglo-Swedish pharmaceutical giant said Tuesday that for the ...

A new image has surfaced, showing an iMac screen with an Apple logo on its "chin," suggesting that Apple scrapped the design at some point in the process.

A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.

U.K.-based drug giant AstraZeneca will make what it calls its single-largest manufacturing investment in the world with a new facility in Virginia.

Pharmaceutical giant AstraZeneca will build a multibillion-dollar manufacturing center somewhere in Virginia.

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is ...

The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several manufacturing facilities in several states.

AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030.

On July 21, AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence in the company's largest market.